Successful treatment of acquired haemophilia A

被引:1
|
作者
Andrea, Kovacs [1 ]
Balazs, Tajti [1 ]
Istvan, Szoboszlay [2 ]
Zsuzsanna, Bereczky [3 ]
Peter, Ilonczai [1 ]
机构
[1] Markhot Ferenc Oktatokorhaz & Rendeloint, Belgyogyaszati Osztaly, Eger, Hungary
[2] Markhot Ferenc Oktatokorhaz & Rendeloint, Kozponti Lab, Eger, Hungary
[3] Debreceni Egyet, Altalanos Orvostud Kar, Klin Kozpont, Lab Med Int,Klin Lab Kutato Tanszek, Debrecen, Hungary
关键词
acquired haemophilia; coagulation factor; activated partial thromboplastin time; MANAGEMENT; PROPHYLAXIS; INHIBITORS; DIAGNOSIS; THERAPY;
D O I
10.1556/650.2021.32245
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acquired haemophilia A is a rare autoimmune disorder, in which antibodies are formed against coagulation factor VIII. The effect of the inhibitor on blood clotting results in severe, life-threatening bleeding diathesis. The patient's life depends on the rapid diagnosis: besides the characteristic clinical presentation, a prolonged activated partial thromboplastin time, which is not corrigible with normal plasma, suggests the existence of the disorder. In the case of the female patient who was referred to our hospital due to severe anaemia, acquired haemophilia A was diagnosed rapidly, the day after her admission. We used activated prothrombin complex concentrate to stop the bleeding, and introduced immunosuppressive therapy. The early recognition of the disease and immediate initiation of adequate treatment resulted in the patient's full recovery. With our case presentation, we would like to draw attention to the fact that the rapid diagnosis of acquired haemophilia A depends on the determination of a simple, easily accessible coagulation parameter, the activated partial thromboplastin time and on the immediate recognition of its incorrigible prolongation.
引用
收藏
页码:1977 / 1981
页数:5
相关论文
共 50 条
  • [41] Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience
    Zanon, Ezio
    Pasca, Samantha
    Borchiellini, Alessandra
    Lodigiani, Corrado
    Molinari, Angelo C.
    Ambaglio, Chiara
    Valeri, Federica
    Preti, Paola S.
    Moscatelli, Paolo
    Simioni, Paolo
    BLOOD TRANSFUSION, 2020, 18 (04) : 312 - 321
  • [42] The management of acquired haemophilia
    Green, D.
    HAEMOPHILIA, 2006, 12 : 32 - 36
  • [43] Expecting the unexpected: Acquired haemophilia A in a patient with homozygous factor V deficiency
    Denny, Nicholas
    Scott, Martin
    Hay, Charles
    Thachil, Jecko
    HAEMOPHILIA, 2019, 25 (02) : E101 - E103
  • [44] Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy
    Machado, P.
    Raya, J. M.
    Martin, T.
    Morabiot, L.
    Brito, M. L.
    Rodriguez-Martin, J. M.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 87 (05) : 545 - 549
  • [45] Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal
    Sumner, M. J.
    Geldziler, B. D.
    Pedersen, M.
    Seremetis, S.
    HAEMOPHILIA, 2007, 13 (05) : 451 - 461
  • [46] Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A
    Kruse-Jarres, R.
    St-Louis, J.
    Greist, A.
    Shapiro, A.
    Smith, H.
    Chowdary, P.
    Drebes, A.
    Gomperts, E.
    Bourgeois, C.
    Mo, M.
    Novack, A.
    Farin, H.
    Ewenstein, B.
    HAEMOPHILIA, 2015, 21 (02) : 162 - 170
  • [47] Management of acquired haemophilia A
    Collins, P. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 226 - 235
  • [48] Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
    Knoebl, P.
    Marco, P.
    Baudo, F.
    Collins, P.
    Huth-Kuhne, A.
    Nemes, L.
    Pellegrini, F.
    Tengborn, L.
    Levesque, H.
    Aspoek, G.
    Heistinger, M.
    Knobl, P.
    Makipernaa, A.
    Andre, H.
    Aouba, A.
    Bellucci, Sylvia
    Beurrier, P.
    Borg, J. Y.
    Darnige, L.
    Devignes, J.
    D'Oiron, R.
    Gautier, P.
    Gay, V.
    Girault, S.
    Gruel, Y.
    Guerin, V.
    Hezard, N.
    Khellaf, M.
    Koenig, M.
    Lifermann, F.
    Marlu, R.
    Ninet, Jacques
    Peynet, J.
    Quemeneur, T.
    Rothschild, C.
    Schleinitz, N.
    Sigaud, M.
    Trouillier, S.
    Voisin, S.
    Giebl, A.
    Holstein, K.
    Loreth, R. M.
    Steigerwald, U.
    Tiede, A.
    Theodossiades, G.
    Radvanyi, G.
    Schlammadinger, A.
    Barillari, G.
    Pasca, S.
    Baudo, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (04) : 622 - 631
  • [49] Inhibitor eradication and treatment for acquired hemophilia A
    Franchini, Massimo
    Focosi, Daniele
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (06) : 233 - 240
  • [50] Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy
    P. Machado
    J. M. Raya
    T. Martín
    L. Morabito
    M. L. Brito
    J. M. Rodríguez-Martín
    International Journal of Hematology, 2008, 87 : 545 - 549